Abstract:Myeloid-derived suppressor cells (MDSCs) are a hetero geneous group of cells, which can suppress the immune response, promote tumor progression and impair the efficacy of immunotherapies. Consequently, the pharmacological targeting of MDSC is emerging as a new immunotherapeutic strategy to stimulate the natural anti-tumor immune response and potentiate the efficacy of immunotherapies. Herein, we leveraged genetically modified models and a small molecule inhibitor to validate Calcium-Calmodulin Kinase Kinase 2 (CaMKK2) as a druggable target to control MDSC accumulation in tumor-bearing mice. The results indicated that deletion of CaMKK2 in the host attenuated the growth of engrafted tumor cells, and this phenomenon was associated with increased antitumor T cell response and decreased accumulation of MDSC. The adoptive transfer of MDSC was sufficient to restore the ability of the tumor to grow in Camkk2 -/- mice, confirming the key role of MDSC in the mechanism of tumor rejection. In vitro studies indicated that blocking of CaMKK2 is sufficient to impair the yield of MDSC. Surprisingly, MDSC generated from Camkk2 -/- bone marrow cells also showed a higher ability to terminally differentiate toward more immunogenic cell types (e.g inflammatory macrophages and dendritic cells) compared to wild type (WT). Higher intracellular levels of reactive oxygen species (ROS) accumulated in Camkk2 -/- MDSC, increasing their susceptibility to apoptosis and promoting their terminal differentiation toward more mature myeloid cells. Mechanistic studies indicated that AMP-activated protein kinase (AMPK), which is a known CaMKK2 proximal target controlling the oxidative stress response, fine-tunes ROS accumulation in MDSC. Accordingly, failure to activate the CaMKK2-AMPK axis can account for the elevated ROS levels in Camkk2 -/- MDSC. These results highlight CaMKK2 as an important regulator of the MDSC lifecycle, identifying this kinase as a new druggable target to restrain MDSC expansion and enhance the efficacy of anti-tumor immunotherapy.

CaMKK2 Suppresses Muscle Regeneration Through the Inhibition of Myoblast Proliferation and Differentiation

Mtor is Necessary for Proper Satellite Cell Activity and Skeletal Muscle Regeneration.

Extracellular Signal–Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Pathway is Involved in Myostatin-Regulated Differentiation Repression

Hsp70 interacts with MAPK-activated protein kinase 2 to regulate p38MAPK stability and myoblast differentiation during skeletal muscle regeneration.

Muscle-selective knockout of AMPKα2 does not exacerbate diet-induced obesity probably related to altered myokines expression.

MiR‐222‐3p suppresses C2C12 myoblast proliferation and differentiation via the inhibition of IRS‐1/PI3K/Akt pathway

CaMKK2 alleviates myocardial ischemia/reperfusion injury by inhibiting oxidative stress and inflammation via the action on the AMPK-AKT-GSK-3β/Nrf2 signaling cascade

Foxk1 Promotes Cell Proliferation and Represses Myogenic Differentiation by Regulating Foxo4 and Mef2.

Activated Integrin-Linked Kinase Negatively Regulates Muscle Cell Enhancement Factor 2c in C2c12 Cells

Mtorc2 Affects the Maintenance of the Muscle Stem Cell Pool

CircRIMKLB Promotes Myoblast Proliferation and Inhibits Differentiation by Sponging Mir-29C to Release KCNJ12

Mst1/2 is Necessary for Satellite Cell Differentiation to Promote Muscle Regeneration

Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling

circHIPK3 regulates proliferation and differentiation of myoblast through the miR-7/TCF12 pathway.

Muscle cell-derived Ccl8 is a negative regulator of skeletal muscle regeneration

Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells

Calcium/calmodulin-dependent kinase kinase 2 regulates hematopoietic stem and progenitor cell regeneration

CircRIMKLB Promotes Myoblasts Proliferation and Inhibits Differentiation via Sponging miR-29c to Release KCNJ12

MST1/2 regulates fibro/adipogenic progenitor fate decisions in skeletal muscle regeneration

Calcium/Calmodulin-Dependent Protein Kinase IV Mediates IFN-γ-Induced Immune Behaviors in Skeletal Muscle Cells

Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration